Growth through acquisitions National HME has expanded its hospice DME footprint through strategic acquisitions, most notably the 2023 Hospice Source acquisition, signaling a growth strategy that increases market reach, cross-sell opportunities, and bundling potential for services and equipment.

Leadership continuity Multiple leadership changes in recent years including a CEO transition in 2021 and a new chair/CEO in 2022 suggest a focus on strategic pivots and potential willingness to adopt new technologies, services, or financing structures that can be leveraged in sales conversations.

Proprietary tech focus National HME emphasizes a proprietary technology solution, Hospice Cloud Pro, to improve operating efficiencies, enabling a sales angle around hardware, software, and managed services that align with cost-reduction goals for hospice providers.

Mid-market scale With 201-500 employees and revenue in the $100M–$250M range, National HME sits in a mid-market tier that often seeks scalable, integrated DME solutions and service bundles, presenting opportunities for multi-location contracts and centralized procurement programs.

Healthcare network fit As a large hospice DME provider within hospitals and health care, there are potential upsell paths to ancillary services, analytics, ETL/reporting capabilities, and expanded equipment lines to support end-of-life and palliative care programs across affiliated facilities.